Biodistribution studies also showed that compared to [177Lu]Lu-PSMA-10, [177Lu]Lu-11 had a lower kidney uptake (173 vs 33.2 %IA/g, 1h post-injection) but also a lower uptake in LNCaP tumor xenografts (12.2 vs 3.4 %IA/g) 24. The gene discussed is FOLH1; the disease is neoplasm.